Active Shortage

APO-ESOMEPRAZOLE

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-ESOMEPRAZOLE in Canada?

Yes. APO-ESOMEPRAZOLE 20MG has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is APO-ESOMEPRAZOLE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-ESOMEPRAZOLE be available again?

The manufacturer's estimated resolution date is November 13, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products · 5 same form & route

Expected resolution~1 day remaining (estimate)

Affected strength20MG

Report last updated2026-11-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

NEXIUM - 20MG

ASTRAZENECA CANADA INC

20MG · DIN 02244521

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ESOMEPRAZOLE

PRO DOC LIMITEE

20MG · DIN 02394839

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

RIVA-ESOMEPRAZOLE

LABORATOIRE RIVA INC.

20MG · DIN 02557673

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

M-ESOMEPRAZOLE

MANTRA PHARMA INC

20MG · DIN 02520109

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

NEXIUM 24HR

HALEON CANADA ULC

20MG · DIN 02444712

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

NEXIUM - 40MG

ASTRAZENECA CANADA INC

40MG · DIN 02244522

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-11-13

~1 day remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02339099

Strength

20MG

Dosage Form

TABLET (DELAYED-RELEASE)

Route

ORAL

Active Ingredient

ESOMEPRAZOLE

Tier

Unrated

Last Updated

2026-11-05

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-ESOMEPRAZOLE has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-27

Resolved

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244